Last 7 days
-8.4%
Last 30 days
-17.4%
Last 90 days
12.5%
Trailing 12 Months
86.7%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-09-01 | Chivukula Pad | sold | -157,264 | 31.4527 | -5,000 | chief scientific officer & coo |
2023-08-15 | SASSINE ANDY | acquired | 21,248 | 17.374 | 1,223 | chief financial officer |
2023-08-01 | Chivukula Pad | sold | -174,550 | 34.91 | -5,000 | chief scientific officer & coo |
2023-07-14 | Kummerfeld Keith C | sold | -243,880 | 35.00 | -6,968 | see remarks |
2023-07-14 | Kummerfeld Keith C | acquired | 62,408 | 8.95642 | 6,968 | see remarks |
2023-07-14 | Chivukula Pad | sold | -875,250 | 35.01 | -25,000 | chief scientific officer & coo |
2023-07-03 | Chivukula Pad | sold | -143,750 | 28.75 | -5,000 | chief scientific officer & coo |
2023-06-01 | Chivukula Pad | sold | -135,800 | 27.16 | -5,000 | chief scientific officer & coo |
2023-05-11 | Chivukula Pad | sold | -239,652 | 30.24 | -7,925 | chief scientific officer & coo |
2023-05-10 | Chivukula Pad | sold | -512,250 | 30.00 | -17,075 | chief scientific officer & coo |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-08-24 | Alberta Investment Management Corp | new | - | 275,385 | 275,385 | -% |
2023-08-22 | VIRGINIA RETIREMENT SYSTEMS ET AL | new | - | 321,216 | 321,216 | -% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -2.56 | 117,446 | 825,496 | -% |
2023-08-21 | OSAIC HOLDINGS, INC. | reduced | -7.53 | 4,606 | 47,888 | -% |
2023-08-16 | Nuveen Asset Management, LLC | added | 27.11 | 1,850,360 | 5,401,360 | -% |
2023-08-15 | LAZARD ASSET MANAGEMENT LLC | added | 28.29 | 119,000 | 341,000 | -% |
2023-08-15 | WELLS FARGO & COMPANY/MN | reduced | -4.38 | 554,612 | 4,405,100 | -% |
2023-08-15 | ALLIANCEBERNSTEIN L.P. | added | 255 | 1,778,570 | 2,325,090 | -% |
2023-08-15 | Formidable Asset Management, LLC | unchanged | - | 45,000 | 429,000 | 0.09% |
2023-08-15 | GOLDMAN SACHS GROUP INC | added | 19.76 | 3,273,000 | 10,833,200 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 09, 2023 | vanguard group inc | 5.46% | 1,450,425 | SC 13G | |
Feb 08, 2023 | state street corp | 8.50% | 2,257,846 | SC 13G/A | |
Feb 03, 2023 | sumitomo mitsui trust holdings, inc. | 5.45% | 1,449,060 | SC 13G/A | |
Feb 01, 2023 | federated hermes, inc. | 16.00% | 4,239,554 | SC 13G/A | |
Jan 31, 2023 | blackrock inc. | 7.1% | 1,884,885 | SC 13G/A | |
Apr 11, 2022 | state street corp | 12.20% | 3,217,957 | SC 13G/A | |
Feb 14, 2022 | nikko asset management americas, inc. | 5.15% | 1,357,472 | SC 13G | |
Feb 14, 2022 | federated hermes, inc. | 14.02% | 3,694,929 | SC 13G | |
Feb 14, 2022 | price t rowe associates inc /md/ | 0.0% | 15,039 | SC 13G/A | |
Feb 11, 2022 | state street corp | 7.80% | 2,056,074 | SC 13G |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 05, 2023 | 4 | Insider Trading | |
Sep 01, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 17, 2023 | 4 | Insider Trading | |
Aug 14, 2023 | 8-K | Current Report | |
Aug 07, 2023 | 10-Q | Quarterly Report | |
Aug 07, 2023 | 424B5 | Prospectus Filed | |
Aug 07, 2023 | 8-K | Current Report | |
Aug 03, 2023 | 4 | Insider Trading | |
Aug 03, 2023 | 4 | Insider Trading | |
Aug 03, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABBV | 271.1B | 56.0B | 3.50% | 10.46% | 31.22 | 4.84 | -2.31% | -31.27% |
BGNE | 258.4B | 1.8B | -3.35% | 26.15% | -149.17 | 142.72 | 69.45% | 14.65% |
VRTX | 91.3B | 9.5B | 1.11% | 26.35% | 27.14 | 9.61 | 13.83% | 5.33% |
REGN | 88.1B | 12.7B | -2.05% | 20.27% | 20.49 | 6.95 | -10.94% | -24.40% |
ALNY | 21.7B | 1.2B | -8.20% | -15.77% | -20.42 | 17.55 | 39.94% | -8.44% |
SRPT | 11.2B | 1.0B | 5.15% | 8.54% | -12.29 | 11.11 | 20.15% | -79.16% |
UTHR | 10.5B | 2.1B | -3.19% | 8.81% | 12.04 | 4.97 | 18.01% | 38.16% |
MID-CAP | ||||||||
BPMC | 3.0B | 225.6M | 0.06% | -27.49% | -5.4 | 13.27 | -2.11% | 21.02% |
MDGL | 2.9B | - | -11.82% | 158.82% | -8.93 | - | - | -28.88% |
RARE | 2.6B | 402.9M | 1.47% | -16.95% | -3.63 | 6.49 | 20.50% | -42.46% |
MRTX | 2.1B | 27.2M | -3.08% | -49.09% | -2.89 | 78.22 | - | -14.43% |
SMALL-CAP | ||||||||
CYTK | 3.1B | - | -6.35% | -39.40% | -7.31 | 33.28 | 34.30% | -149.91% |
CPRX | 1.3B | 302.9M | -15.88% | -2.65% | 11.18 | 4.26 | 77.72% | 112.02% |
MGNX | 289.9M | 152.5M | -10.34% | 48.10% | 38.91 | 1.9 | 127.84% | 103.41% |
CRBP | 28.7M | - | 0.62% | 3389.00% | -0.62 | - | - | -31.51% |
-13.1%
-2.8%
22.4%
-12.9%
100%
100%
83.1%
Y-axis is the maximum loss one would have experienced if Arcturus Therapeutics Holdings was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | -5.9% | 264,466,000 | 281,040,000 | 205,999,000 | 51,500,000 | 40,568,000 | 15,476,000 | 12,359,000 | 8,803,000 | 8,699,000 | 9,020,000 | 9,539,000 | 10,269,000 | 11,254,000 | 19,085,000 | 20,789,000 | 25,398,000 | 25,503,000 | 17,736,000 | 15,753,000 | 11,618,000 | 9,544,000 |
Operating Expenses | 8.2% | 220,440,000 | 203,729,000 | 193,822,000 | 198,420,000 | 204,502,000 | 211,041,000 | 215,211,000 | 205,092,000 | 172,105,000 | 128,748,000 | 81,063,000 | 61,528,000 | 49,191,000 | 47,552,000 | 46,302,000 | 40,805,000 | 37,650,000 | 39,383,000 | 37,564,000 | 40,474,000 | 49,832,000 |
S&GA Expenses | 4.5% | 51,335,000 | 49,103,000 | 46,071,000 | 45,017,000 | 43,389,000 | 42,438,000 | 41,451,000 | 39,679,000 | 34,391,000 | 28,769,000 | 23,217,000 | 15,974,000 | 14,283,000 | 13,319,000 | 12,662,000 | 14,312,000 | 14,241,000 | 19,018,000 | 20,582,000 | 24,086,000 | 32,932,000 |
R&D Expenses | 9.4% | 169,105,000 | 154,626,000 | 147,751,000 | 153,403,000 | 161,113,000 | 168,603,000 | 173,760,000 | 165,413,000 | 137,714,000 | 99,979,000 | 57,846,000 | 45,554,000 | 34,908,000 | 34,233,000 | 33,640,000 | 26,493,000 | 23,409,000 | 20,365,000 | 16,982,000 | 16,388,000 | 16,900,000 |
EBITDA | -100.0% | - | 208,125,000 | 12,984,000 | - | - | - | - | -19,845,000 | -19,952,000 | -20,104,000 | -20,152,000 | -20,694,000 | -20,519,000 | -20,298,000 | -20,410,000 | -20,368,666 | -20,366,000 | -20,478,000 | -21,057,000 | - | - |
EBITDA Margin | -100.0% | - | 0.74 | 0.06 | - | - | - | - | -2.25 | -2.29 | -2.23 | -2.11 | -2.02 | -1.82 | -1.06 | -0.98 | -0.80 | -0.80 | -1.15 | -1.34 | - | - |
Interest Expenses | -6.8% | 2,560,000 | 2,746,000 | 813,000 | 755,000 | 698,000 | 684,000 | 684,000 | 1,092,000 | 912,000 | 692,000 | 751,000 | 356,000 | 531,000 | 752,000 | 691,000 | 677,333 | 680,000 | 668,000 | 146,000 | - | - |
Earnings Before Taxes | -103.8% | -2,232,000 | 58,588,000 | 10,644,000 | - | -145,464,000 | -204,676,000 | -203,674,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBT Margin | -100.0% | - | 0.72 | 0.05 | - | - | - | - | -2.47 | -2.50 | -2.42 | -2.28 | -2.12 | -1.94 | -1.14 | -1.05 | -0.86 | -0.85 | -1.23 | -1.38 | - | - |
Net Income | -27.8% | 80,285,000 | 111,272,000 | 9,349,000 | -146,661,000 | -165,479,000 | -198,497,000 | -203,674,000 | -196,115,000 | -163,035,000 | -118,717,000 | -72,148,000 | -52,033,000 | -38,462,000 | -28,884,000 | -25,991,000 | -16,013,000 | -12,833,000 | -22,098,000 | -21,785,000 | -28,406,000 | -39,800,000 |
Net Income Margin | -100.0% | - | 0.40 | 0.05 | -2.85 | -4.08 | -12.83 | -16.48 | -22.28 | -18.74 | -13.16 | -7.56 | -5.07 | -3.42 | -1.51 | -1.25 | - | - | - | - | - | - |
Free Cashflow | -100.0% | - | 38,855,000 | 24,267,000 | -175,800,000 | -149,627,000 | -146,531,000 | -138,449,000 | -102,163,000 | -100,055,000 | -75,671,000 | -44,603,000 | -45,127,000 | -31,811,000 | -13,774,000 | -7,263,000 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2018Q4 |
Assets | -8.5% | 431 | 471 | 450 | 294 | 337 | 342 | 393 | 435 | 449 | 481 | 476 | 323 | 150 | 72.00 | 82.00 | 87.00 | 71.00 | 44.00 |
Current Assets | -9.3% | 385 | 425 | 403 | 247 | 292 | 327 | 379 | 421 | 438 | 470 | 468 | 314 | 142 | 64.00 | 74.00 | 79.00 | 63.00 | 42.00 |
Cash Equivalents | -1.4% | 323 | 328 | 392 | 238 | 283 | 320 | 373 | 414 | 434 | 467 | 463 | 307 | 136 | 59.00 | 71.00 | 74.00 | 56.00 | 37.00 |
Net PPE | 0.7% | 13.00 | 13.00 | 12.00 | 11.00 | 9.00 | 8.00 | 6.00 | 5.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Liabilities | 2.7% | 145 | 142 | 180 | 148 | 166 | 157 | 165 | 175 | 143 | 129 | 80.00 | 61.00 | 57.00 | 55.00 | 56.00 | 51.00 | 49.00 | 31.00 |
Current Liabilities | 0.2% | 90.00 | 90.00 | 127 | 76.00 | 93.00 | 107 | 100 | 118 | 71.00 | 53.00 | 50.00 | 28.00 | 23.00 | 22.00 | 21.00 | 22.00 | 16.00 | 13.00 |
LT Debt, Current | - | - | - | 61.00 | 28.00 | 27.00 | 24.00 | 22.00 | - | - | - | 1.00 | - | - | - | - | - | - | - |
LT Debt, Non Current | - | - | - | - | 32.00 | 36.00 | 39.00 | 41.00 | 42.00 | 56.00 | 58.00 | 14.00 | 15.00 | 15.00 | 15.00 | 15.00 | 10.00 | 10.00 | 10.00 |
Shareholder's Equity | -13.4% | 285 | 329 | 270 | 146 | 171 | 185 | 228 | 259 | 306 | 353 | 397 | 262 | 93.00 | 17.00 | 26.00 | 36.00 | 22.00 | 14.00 |
Retained Earnings | -18.3% | -339 | -287 | -338 | -455 | -420 | -398 | -347 | -308 | -254 | -200 | -143 | -112 | -91.71 | -81.44 | -71.67 | -60.68 | -53.25 | -44.87 |
Additional Paid-In Capital | 1.4% | 625 | 617 | 608 | 601 | 591 | 583 | 576 | 568 | 560 | 553 | 540 | 374 | 185 | 98.00 | 97.00 | 97.00 | 75.00 | 58.00 |
Shares Outstanding | 0.1% | 27.00 | 27.00 | 27.00 | 26.00 | 26.00 | 26.00 | 26.00 | 26.00 | 26.00 | 26.00 | 26.00 | 23.00 | 19.00 | 15.00 | 12.00 | 13.00 | 10.00 | 10.00 |
Cashflow (Last 12 Months) | (In Thousands) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | 194.0% | 132,789 | 45,161 | 31,993 | -170,763 | -145,010 | -141,132 | -135,043 | -99,178 | -98,402 | -73,953 | -42,861 | -43,767 | -30,726 | -12,892 | -6,445 | -4,670 | -8,629 | -23,958 | -20,760 | -27,180 | -16,404 |
Share Based Compensation | 3.5% | 32,531 | 31,422 | 30,611 | 31,599 | 29,033 | 29,299 | 28,915 | 24,223 | 19,341 | 12,902 | 6,764 | 4,735 | 3,130 | 2,432 | 1,982 | 1,691 | 1,895 | 1,989 | 1,259 | 2,348 | 332 |
Cashflow From Investing | -11.6% | -7,038 | -6,306 | -7,726 | -5,037 | -4,617 | -5,399 | -3,406 | -2,985 | -1,653 | -1,718 | -1,742 | -1,360 | -1,085 | -882 | -818 | 1,766 | 9,748 | 13,352 | 22,134 | 31,292 | 24,084 |
Cashflow From Financing | -0.5% | -30,722 | -30,559 | -2,859 | -397 | 1,515 | 1,340 | 48,016 | 210,987 | 397,518 | 483,039 | 436,145 | 277,978 | 112,082 | 35,305 | 41,907 | 62,398 | 19,706 | - | 10,204 | -76.00 | 702 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenue: | ||||
Total revenue | $ 10,519 | $ 27,093 | $ 90,804 | $ 32,337 |
Operating expenses: | ||||
Research and development, net | 52,668 | 38,189 | 104,436 | 83,082 |
General and administrative | 13,225 | 10,993 | 26,987 | 21,723 |
Total operating expenses | 65,893 | 49,182 | 131,423 | 104,805 |
Loss from operations | (55,374) | (22,089) | (40,619) | (72,468) |
Loss from equity-method investment | (131) | (515) | ||
Gain (loss) from foreign currency | 149 | 1,217 | (179) | 1,375 |
Gain on debt extinguishment | 33,953 | |||
Finance income (expense), net | 3,252 | (560) | 5,729 | (1,124) |
Net loss before income taxes | (51,973) | (21,563) | (1,116) | (72,732) |
Provision for income taxes | 577 | 680 | ||
Net loss | $ (52,550) | $ (21,563) | $ (1,796) | $ (72,732) |
Net loss per share: | ||||
Basic | $ (1.98) | $ (0.82) | $ (0.07) | $ (2.75) |
Diluted | $ (1.98) | $ (0.82) | $ (0.07) | $ (2.75) |
Weighted-average shares outstanding: | ||||
Basic | 26,563 | 26,425 | 26,557 | 26,401 |
Diluted | 26,563 | 26,425 | 26,557 | 26,401 |
Comprehensive loss: | ||||
Net loss | $ (52,550) | $ (21,563) | $ (1,796) | $ (72,732) |
Comprehensive loss | (52,550) | (21,563) | (1,796) | (72,732) |
Collaboration Revenue [Member] | ||||
Revenue: | ||||
Total revenue | 9,565 | $ 27,093 | 89,294 | $ 32,337 |
Grant Revenue [Member] | ||||
Revenue: | ||||
Total revenue | $ 954 | $ 1,510 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 323,471 | $ 391,883 |
Restricted cash | 55,000 | |
Accounts receivable | 2,799 | 2,764 |
Prepaid expenses and other current assets | 3,974 | 8,686 |
Total current assets | 385,244 | 403,333 |
Property and equipment, net | 12,722 | 12,415 |
Operating lease right-of-use asset, net | 30,553 | 32,545 |
Non-current restricted cash | 2,127 | 2,094 |
Total assets | 430,646 | 450,387 |
Current liabilities: | ||
Accounts payable | 13,619 | 7,449 |
Accrued liabilities | 28,763 | 30,232 |
Current portion of long-term debt | 60,655 | |
Deferred revenue | 47,963 | 28,648 |
Total current liabilities | 90,345 | 126,984 |
Deferred revenue, net of current portion | 25,725 | 20,071 |
Operating lease liability, net of current portion | 28,111 | 30,216 |
Other non-current liabilities | 1,290 | 2,804 |
Total liabilities | 145,471 | 180,075 |
Stockholders’ equity | ||
Common stock, $0.001 par value; 60,000 shares authorized; issued and outstanding shares were 26,574 at June 30, 2023 and 26,555 at December 31, 2022 | 27 | 27 |
Additional paid-in capital | 625,085 | 608,426 |
Accumulated deficit | (339,937) | (338,141) |
Total stockholders’ equity | 285,175 | 270,312 |
Total liabilities and stockholders’ equity | $ 430,646 | $ 450,387 |